Generate Biomedicines, Inc. (GENB)
15.72
+0.33
(+2.14%)
USD |
NASDAQ |
Sep 11, 16:00
15.50
-0.22
(-1.40%)
After-Hours: 20:00
Generate Biomedicines Price to Book Value : 4.422 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.422 |
| September 10, 2026 | 4.329 |
| September 09, 2026 | 4.365 |
| September 08, 2026 | 4.472 |
| September 04, 2026 | 4.610 |
| September 03, 2026 | 4.596 |
| September 02, 2026 | 4.579 |
| September 01, 2026 | 4.441 |
| August 31, 2026 | 4.295 |
| August 28, 2026 | 4.312 |
| August 27, 2026 | 4.436 |
| August 26, 2026 | 4.540 |
| August 25, 2026 | 5.732 |
| August 24, 2026 | 4.984 |
| August 21, 2026 | 4.534 |
| August 20, 2026 | 4.497 |
| August 19, 2026 | 4.773 |
| August 18, 2026 | 4.523 |
| August 17, 2026 | 4.413 |
| August 14, 2026 | 4.399 |
| August 13, 2026 | 4.227 |
| August 12, 2026 | 4.244 |
| August 11, 2026 | 4.014 |
| August 10, 2026 | 4.140 |
| August 07, 2026 | 4.036 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.907 |
| August 05, 2026 | 4.076 |
| August 04, 2026 | 4.016 |
| August 03, 2026 | 4.033 |
| July 31, 2026 | 3.938 |
| July 30, 2026 | 3.946 |
| July 29, 2026 | 3.679 |
| July 28, 2026 | 3.696 |
| July 27, 2026 | 3.848 |
| July 24, 2026 | 3.769 |
| July 23, 2026 | 3.890 |
| July 22, 2026 | 3.910 |
| July 21, 2026 | 4.047 |
| July 20, 2026 | 3.820 |
| July 17, 2026 | 3.814 |
| July 16, 2026 | 3.842 |
| July 15, 2026 | 3.957 |
| July 14, 2026 | 3.997 |
| July 13, 2026 | 4.016 |
| July 10, 2026 | 4.029 |
| July 09, 2026 | 4.422 |
| July 08, 2026 | 4.464 |
| July 07, 2026 | 4.562 |
| July 06, 2026 | 4.759 |
| July 02, 2026 | 4.897 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 17.89 |
| Intellia Therapeutics, Inc. | 2.259 |
| Prime Medicine, Inc. | 14.21 |
| Moderna, Inc. | 8.496 |
| Beam Therapeutics, Inc. | 2.321 |
Price to Book Value Related Metrics
| PS Ratio | 39.01 |
| Price | 15.72 |
| Earnings Yield | -29.38% |
| Market Cap | 2.016B |